Natalizumab Treatment of Progressive Multiple Sclerosis

Clinical trial NCT01077466 · COMPLETED

Trial details

NCT number: NCT01077466
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2010-03-01
Primary completion: 2012-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.